PerkinElmer Inc., a leading innovator driving a healthier world, will announce its fourth quarter and full year 2022 financial results on Tuesday, February 14th, 2023 prior to market open. Prahlad Singh, president and chief executive officer, and Max Krakowiak, chief financial officer, will host a conference call at 8:00 a.m. ET the same day to discuss the results and answer questions. Don’t miss this chance to hear the latest news from PerkinElmer!
We are pleased to announce that the Company is updating its fourth quarter 2022 guidance as previously provided on November 8, 2022, expecting our results to meet or exceed the guidance provided. To access the call, a live audio webcast will be made available via registration form or on the Investors section of our website. Don’t miss out on this great opportunity and register today!
Factors Affecting Future Performance
Our future financial results, such as estimated adjusted earnings per share, revenue, and revenue growth, are based on our current assumptions and expectations. However, there are a number of important risk factors that could cause these results to differ from what we have projected. Risks include the completion of quarterly and year-end closing procedures for the fourth quarter and fiscal year ended January 1, 2023, as well as other factors outlined in our most recent quarterly report on Form 10-Q and in our other filings with the Securities and Exchange Commission. We are committed to updating any forward-looking statements with any developments that may occur after this press release.
At PerkinElmer, our mission is to empower scientists, researchers, and clinicians to solve their most pressing challenges in science and healthcare. We are committed to making the world healthier through innovative solutions for the diagnostics, life sciences, food, and applied markets. Our diverse team of more than 16,000 employees around the world is passionate about helping our customers create healthier families, enhance quality of life, and promote well-being and longevity. In 2021, we reported annual revenue of $5 billion, serve customers in over 190 countries, and are part of the S&P 500 index.